Bristol-Myers Squibb
2,502 hedge funds and large institutions have $118B invested in Bristol-Myers Squibb in 2022 Q1 according to their latest regulatory filings, with 211 funds opening new positions, 987 increasing their positions, 989 reducing their positions, and 114 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,502
Holders Change
+70
Holders Change %
+2.88%
% of All Funds
39.59%
Holding in Top 10
85
Holding in Top 10 Change
+21
Holding in Top 10 Change %
+32.81%
% of All Funds
1.35%
New
211
Increased
987
Reduced
989
Closed
114
Calls
$2.4B
Puts
$2B
Net Calls
+$392M
Net Calls Change
-$9.36M
Top Buyers
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$557M |
| 2 |
Berkshire Hathaway
Omaha,
Nebraska
|
-$324M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$291M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$263M |
| 5 |
Nordea Investment Management
Stockholm,
Sweden
|
-$200M |
